Lucy A Chester, Lucia R Valmaggia, Matthew J Kempton, Edward Chesney, Dominic Oliver, Emily P Hedges, Elise Klatsa, Daniel Stahl, Mark van der Gaag, Lieuwe de Haan, Barnaby Nelson, Patrick McGorry, G Paul Amminger, Anita Riecher-Rössler, Erich Studerus, Rodrigo Bressan, Neus Barrantes-Vidal, Marie-Odile Krebs, Birte Glenthøj, Merete Nordentoft, Stephan Ruhrmann, Gabriele Sachs, Philip McGuire
AIMS: Evidence for case-control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of psychosis. Secondary aims were to assess associations between cannabis use and the persistence of psychotic symptoms, and with functional outcome...
April 18, 2023: Psychiatry and Clinical Neurosciences